Ullem Scott B. — SEC Form 4 filings
SEC reporting owner CIK 1446989. 40 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 40 filings on record, filed 2024-02-01 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 22 legs across 15 filings — 143,215 shares, $11,464,716 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 72.
- Largest priced transaction: sale of 11,250 shares @ $75.76 ($852,272) in Edwards Lifesciences Corp, filed 2025-02-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Edwards Lifesciences Corp (EW) | CVP, Chief Financial Officer | 26 | — | 22 legs · 143,215 sh · $11,464,716 | 58 |
| ILLUMINA, INC. (ILMN) | Director | 14 | — | — | 14 |
Form 4 filings — Ullem Scott B.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 167 @ $149.19 | EDGAR |
| 2026-05-22 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 2,072 @ $144.83 | EDGAR |
| 2026-05-11 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 19,830 @ $0 · Tax withholding (F): 11,004 @ $79.96 · Option exercise (M): 19,830 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 1,373 @ $83.20 · Tax withholding (F): 1,661 @ $82.76 | EDGAR |
| 2026-05-05 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 620 @ $83.98 · Option exercise (M): 13,000 @ $59.26 · Tax withholding (F): 11,131 @ $82.91 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2026-04-09 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 13,000 @ $59.26 · Sale (S): 4,676 @ $80.50 · Sale (S): 8,324 @ $79.79 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 190 @ $131.55 | EDGAR |
| 2026-03-11 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 13,000 @ $59.26 · Sale (S): 5,099 @ $84.46 · Sale (S): 7,901 @ $85.21 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 199 @ $75.87 | EDGAR |
| 2026-01-05 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 212 @ $117.63 | EDGAR |
| 2025-12-09 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 7,700 @ $59.26 · Sale (S): 7,700 @ $84.47 · Option exercise (M): 7,700 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 13,000 @ $59.26 · Sale (S): 2,974 @ $83.30 · Sale (S): 10,026 @ $83.02 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 252 @ $99.17 | EDGAR |
| 2025-07-02 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 307 @ $81.20 | EDGAR |
| 2025-05-23 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 3,780 @ $0 | EDGAR |
| 2025-05-20 | 4 | ILLUMINA, INC. (ILMN) | Tax withholding (F): 1,070 @ $83.62 | EDGAR |
| 2025-05-12 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 1,200 @ $73.68 | EDGAR |
| 2025-05-09 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 1,406 @ $74.92 · Grant/award (A): 13,400 @ $0 · Option exercise (M): 11,250 @ $45.28 · Sale (S): 11,250 @ $74.40 · Grant/award (A): 75,200 (derivative) @ $0 · Grant/award (A): 13,400 (derivative) @ $0 · +1 more | EDGAR |
| 2025-05-05 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 635 @ $75.65 · Tax withholding (F): 648 @ $75.65 | EDGAR |
| 2025-04-01 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 229 @ $104.92 | EDGAR |
| 2025-03-26 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 11,250 @ $45.28 · Sale (S): 11,250 @ $70.87 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 11,250 @ $45.28 · Sale (S): 3,490 @ $71.38 · Sale (S): 7,760 @ $70.52 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 174 @ $76.19 | EDGAR |
| 2025-02-13 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 11,250 @ $45.28 · Sale (S): 11,250 @ $75.76 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 158 @ $142.06 | EDGAR |
| 2024-12-09 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 11,250 @ $45.28 · Sale (S): 11,250 @ $71.68 · Option exercise (M): 11,250 (derivative) @ $0 | EDGAR |
| 2024-10-01 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 183 @ $122.78 | EDGAR |
| 2024-07-01 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 205 @ $109.65 | EDGAR |
| 2024-06-20 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 5,625 @ $45.28 · Sale (S): 400 @ $88.11 · Sale (S): 5,225 @ $87.47 · Option exercise (M): 5,625 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 5,625 @ $45.28 · Sale (S): 5,625 @ $90.45 · Option exercise (M): 5,625 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 2,622 @ $0 | EDGAR |
| 2024-05-13 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 1,198 @ $86.72 | EDGAR |
| 2024-05-09 | 4 | Edwards Lifesciences Corp (EW) | Grant/award (A): 11,075 @ $0 · Tax withholding (F): 790 @ $85.09 · Grant/award (A): 65,500 (derivative) @ $0 · Grant/award (A): 11,075 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 634 @ $85.06 · Option exercise (M): 7,465 @ $0 · Tax withholding (F): 4,431 @ $85.25 · Option exercise (M): 7,465 (derivative) @ $0 | EDGAR |
| 2024-04-30 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 7,250 @ $36.75 · Sale (S): 700 @ $86.40 · Sale (S): 6,550 @ $85.74 · Option exercise (M): 7,250 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | ILLUMINA, INC. (ILMN) | Grant/award (A): 163 @ $137.68 | EDGAR |
| 2024-04-01 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 7,255 @ $36.75 · Sale (S): 868 @ $95.51 · Sale (S): 6,387 @ $94.81 · Option exercise (M): 7,255 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 7,255 @ $36.75 · Sale (S): 7,255 @ $85.59 · Option exercise (M): 7,255 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Edwards Lifesciences Corp (EW) | Tax withholding (F): 174 @ $86.04 | EDGAR |
| 2024-02-01 | 4 | Edwards Lifesciences Corp (EW) | Option exercise (M): 7,255 @ $36.75 · Sale (S): 7,255 @ $78.29 · Option exercise (M): 7,255 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1446989 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →